Home ProductsPharmaceutical Raw Materials

3-methoxybenzontrile CAS 1527-89-5 as pharmaceutical raw materials

3-methoxybenzontrile CAS 1527-89-5 as pharmaceutical raw materials

    • 3-methoxybenzontrile CAS 1527-89-5  as pharmaceutical raw materials
    • 3-methoxybenzontrile CAS 1527-89-5  as pharmaceutical raw materials
  • 3-methoxybenzontrile CAS 1527-89-5  as pharmaceutical raw materials

    Product Details:

    Place of Origin: China
    Brand Name: BeiLi
    Certification: ISO 9001:2008
    Model Number: MBN.99P.N

    Payment & Shipping Terms:

    Minimum Order Quantity: unlimited
    Price: negotiation
    Packaging Details: plastic drum/carton drum/bag/
    Delivery Time: 3-10 working days
    Payment Terms: negotiation
    Contact Now
    Detailed Product Description
    Synonym: M-Anisonitrile; AKOS B004087; 3-ANISONITRILE; 3-METHOXYBENZONITRILE; CAS No: 1527-89-5
    Molar Mass (g/mol): 133.15 Reach PR#: 05-2119085533-37-0000
    Grade: Pharmaceutical Grade Density: 1.089 G/mL At 25 °C
    P/N#: MBN.99P.N Melting Point: 11.0~112.0ºC(13mmHg)

     

    3-methoxybenzontrile CAS 1527-89-5 as pharmaceutical raw materials

     

     

     

    3-Methoxybenzonitrile, also known as 3-methoxy benzonitrile, m-methoxy benzonitrile, colorless or slightly yellow liquid.

     

    CAS No: 1527-89-5

    EC No: 216-201-3

    Packaging:200kgs/iron drum with plastic lining

     

     

    Chemical Product and Company Identification

    Name: 3-Methoxybenzonitrile, 99%

    Synonyms: m-Anisonitrile; AKOS B004087; 3-ANISONITRILE; 3-METHOXYBENZONITRILE

    Company Identification: Beili Chemicals (Zhangjiagang) Co., Ltd.


     

    Composition, Information on Ingredients

    Substance: 3-Methoxybenzonitrile

    % content: 99+

    CAS Number: 1527-89-5

    EINECS: 216-201-3

    Hazard Symbols: XN


     

    Hazards Identification

    Harmful by inhalation, in contact with skin and if swallowed.

    Potential Health Effects

    The toxicological properties of this material have not been investigated. Use appropriate procedures to prevent opportunities for direct contact with the skin or eyes and to prevent inhalation.

     

     

    Specifications

     

    P/N# MBN.99P.N Grade Pharmaceutical grade
    Purity ≥99.0% Melting range  
    Water   Quality standard meets company specification

     

     

    Application

     

    Used as a pharmaceutical intermediate, it is an important intermediate of the new antipyretic analgesic - tapentadol. The drug is mainly used to relieve moderate and severe acute pain, especially for the relief of adults over 18 years of age. Its quick release tablets were approved by the US Food and Drug Administration (trade name: NUCNTA) in November 2008 to relieve moderate and severe acute pain;Its sustained-release tablets were approved for marketing in August 2012 (trade name: NUCYNTA ER) for the treatment of adult diabetic neuropathy (DPN) -related neuropathic pain.In addition, it also can participate in a variety of organic synthesis.

     

     

    Storage condition

     

    Store in a cool, dry place, avoid direct sunlight. Store in a tightly closed container.

     

     

    Exposure Controls, Personal Protection

    Engineering Controls: Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits.

    Personal Protective Equipment

    Eyes: Wear safety glasses and chemical goggles if splashing is possible.

    Skin: Wear appropriate protective gloves and clothing to prevent skin exposure.

    Clothing: Not available.


     

     

     

     

     

    Contact Details
    BeiLi Chemicals (Zhangjiagang) Co., Ltd.

    Contact Person: lick

    Send your inquiry directly to us (0 / 3000)

    Other Products